EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Feasibility of a novel 5F plastic stent in endoscopic transpapillary gallbladder drainage for acute cholecystitis

Kazunari Nakahara iD, Yosuke Igarashi, Akihiro Sekine, Yusuke Satta, Haruka Niwa, Junya Sato, Shinjiro Kobayashi, Takehito Otsubo, Keisuke Tateishi

Endoscopy International Open · 07.01.2025 · 13 (CP)

DOI: 10.1055/a-2465-7130 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy International Open, erschienen am 07.01.2025. Verfasst von Kazunari Nakahara und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: JSPS KAKENHI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Many reports have demonstrated the efficacy of endoscopic transpapillary gallbladder stenting (EGBS) for acute cholecystitis (AC), most of which have traditionally used a 7F plastic stent. The study aim was to evaluate the efficacy of a novel 5F plastic stent in EGBS for AC. We designed a retrospective study that compared the outcomes between 7F and 5F stents in patients undergoing EGBS. Among 147 patients who underwent endoscopic transpapillary gallbladder drainage for AC between January 2019 and July 2023, 104 who underwent EGBS using a 7F (n = 53) or 5F (n = 51) plastic stent were included in the analysis. The technical success rate for EGBS, clinical success rate for AC, and early adverse events (AEs) rate in the 7F and 5F groups were 92.5% vs 100%, 100% vs 98.0%, and 5.7% vs 3.9%, respectively, with no significant differences. However, only in the 7F group, four patients failed stent insertion and three patients developed postprocedure pancreatitis. Furthermore, incidence of hyperamylasemia was lower in the 5F group (24.5% vs 9.8%, P = 0.047). The late AE rate did not differ significantly between the 7F and 5F groups (14.3% vs 10.0%). The median time to late AE was 238 days for the 7F group and 187 days for the 5F group, with no significant difference. A 5F stent can provide outcomes comparable to those of a 7F stent and help prevent hyperamylasemia.

Schlagwörter

Stichwörter der Autor:innen

ERC topicsPancreatobiliary (ERCP/PTCD)Stones

Autor:innen und Institutionen

  • Department of Gastroenterology, St. Marianna University School of Medicine, Kawasaki, Japan.
  • Department of Gastroenterogical and General Surgery, St. Marianna University School of Medicine, Kawasaki, Japan.

ORCID-Profile: Kazunari Nakahara

Förderung

  • JSPS KAKENHI

Zitieren

APA

Nakahara, K., Igarashi, Y., Sekine, A., Satta, Y., Niwa, H., Sato, J., Kobayashi, S., Otsubo, T., & Tateishi, K. (2025). Feasibility of a novel 5F plastic stent in endoscopic transpapillary gallbladder drainage for acute cholecystitis. Endoscopy International Open, 13(CP). https://doi.org/10.1055/a-2465-7130

Vancouver

Nakahara K, Igarashi Y, Sekine A, Satta Y, Niwa H, Sato J, et al. Feasibility of a novel 5F plastic stent in endoscopic transpapillary gallbladder drainage for acute cholecystitis. Endoscopy International Open. 2025;13(CP). doi:10.1055/a-2465-7130

BibTeX
@article{Nakahara2025,
  author = {Nakahara, Kazunari and Igarashi, Yosuke and Sekine, Akihiro and Satta, Yusuke and Niwa, Haruka and Sato, Junya and Kobayashi, Shinjiro and Otsubo, Takehito and Tateishi, Keisuke},
  title = {Feasibility of a novel 5F plastic stent in endoscopic transpapillary gallbladder drainage for acute cholecystitis},
  journal = {Endoscopy International Open},
  year = {2025},
  volume = {13},
  number = {CP},
  doi = {10.1055/a-2465-7130}
}
Kostenlos starten →